Jordan

The Jordan Food and Drug Administration (JFDA), established under Law No. 31 of 2008 and operating under the Ministry of Health, is the primary authority responsible for regulating pharmaceuticals, medical devices, diagnostics, and food products in Jordan. The JFDA oversees the full product lifecycle, including registration, post-market surveillance, import controls, and licensing of manufacturers and distributors. All health products must be registered with the JFDA prior to importation or sale, with applications reviewed through a structured dossier evaluation process that assesses safety, efficacy, and quality. Medical devices are classified into risk-based categories, and the approval pathway varies accordingly, with higher-risk devices subject to more rigorous technical review.

The JFDA accepts registration dossiers compiled in accordance with the Common Technical Document (CTD) format, aligning with international harmonization standards promoted by the International Council for Harmonisation (ICH) and the Global Harmonization Task Force (GHTF). A local authorized representative or licensed importer is mandatory for all foreign manufacturers seeking market authorization. Jordan has pursued regulatory modernization in recent years, including the adoption of electronic submission portals, recognition of approvals from stringent regulatory authorities such as the US FDA, EMA, and Health Canada as supportive references to expedite review, and participation in regional harmonization initiatives under the Arab Drug Regulatory Authorities (ADRA) framework. Fee structures and dossier requirements differ across product categories, and renewals are typically required every three to five years.

Public procurement of health products in Jordan is centrally managed through the Ministry of Health (MoH), which conducts national tenders for pharmaceuticals, medical devices, diagnostics, and consumables required by government hospitals and primary healthcare centers. The Jordan Pharmaceutical Manufacturers Association (JPMA) and the Central Purchasing Directorate within the MoH play key roles in coordinating procurement cycles, which are typically annual. The Royal Medical Services (RMS), serving military and security personnel, and the University of Jordan Hospital operate semi-independent procurement mechanisms but largely follow similar tendering principles. Price controls and reference pricing policies are applied to many product categories, and local or regional manufacturing can confer pricing or preference advantages in tender evaluations under national support-for-industry policies.

Jordan also benefits from several donor-funded and multilateral procurement channels that supplement public sector supply, particularly for essential medicines, vaccines, and diagnostic tools. Organizations including UNICEF, the World Health Organization (WHO), and USAID have historically supported procurement for vulnerable populations and specific health programs such as maternal and child health and infectious disease control. The country participates in pooled procurement mechanisms facilitated by regional and international bodies, which can allow access to negotiated pricing. The private pharmaceutical and medical device market is well developed in Jordan, with a network of licensed distributors, private hospital groups, and retail pharmacies procuring independently through commercial channels. Jordan also serves as a regional re-export hub for health products destined for neighboring markets, adding a cross-border trade dimension to the overall market structure.